
Employer Strategies
SmithRx
Key Takeaways
Network discount guarantees measure average discounts off AWP within claim buckets the PBM defines.
Rebate guarantees depend on contract definitions that can shrink the claim count and overstate per-claim value.
Claims-level data, audit rights, and PMPM trend give plan sponsors a clearer read on PBM performance.
Originally Published: November 16, 2023 | Updated: November 12, 2026
Most pharmacy benefit manager (PBM) contracts hold the PBM accountable through two kinds of performance guarantees: pharmacy network discount guarantees and manufacturer rebate payment guarantees. Evaluating PBMs on these metrics has become industry standard, largely because the traditional PBM black box offers few other ways to measure performance.
Yet many employers see drug spend rise after signing a contract with stronger guarantees on paper. The explanation for this phenomenon lies in how each PBM guarantee is defined, categorized, and reconciled. Evaluating PBM contract performance guarantees starts with those mechanics, then shifts the measure of success to what the plan actually pays.
Pharmacy Network Discount Guarantees
While discount guarantees seem logical in theory, in practice they can be of dubious value as they are built on two concepts which are vague and manipulatable: Average Wholesale Price (AWP) and drug categories.
The majority of pharmacy benefits contracts utilize the pricing construct of AWP to benchmark the pharmacy network discount guarantees. The best way to think of AWP is the sticker price of the drug. Similar to the sticker price of a car, it is an inflated number that does not accurately reflect the average price at which the product sells. In fact, it can vary so wildly by manufacturer (particularly with generic drugs) that it can seem arbitrary.
Pharmacy claims can come from different types of pharmacies (known as channels) like retail pharmacies, mailorder pharmacies, and specialty pharmacies. They can also come in different drug types (brand vs. generic) and days supply (e.g., 30-day, 90-day). Typically, pharmacy network discount guarantees are bucketed into different categories which combine the pharmacy, drug type, and days supply segmentation (e.g., retail generic 30-day, mail brand 90-day) and then claims are sorted into those categories for the purpose of reconciling against those guarantees.
On the surface this seems fairly straightforward but problems can arise when simple questions are asked, such as:
What if the drug is a 34day supply?
If a member gets a specialty medication at a retail pharmacy does the claim go in the retail bucket?
Is the drug a brand or a generic?
How a PBM chooses to answer questions like these (and many more) can mean the difference between achieving the promised guarantees or missing them. A seemingly aggressive set of pharmacy network discount guarantees may not always yield the expected savings outcome due to how a PBM might rearrange definitions and categories.
In summary, pharmacy network discount guarantees are an average percentage discount off an arbitrarily set price (AWP) across a PBM-determined bucket of claims. These guarantees can offer the illusion of accountability for employer groups, but lack the precision and specificity to be truly effective.
Manufacturer Rebate Payment Guarantees
The most common structure for manufacturer rebate guarantees is one based on a perbrand guarantee that is segmented by category (e.g., 30-day, 90-day, mail, specialty). To make sense of this concept it is important to get a foundational understanding of how rebates work.
Manufacturer rebates are a common mechanism in many industries (e.g., auto dealerships), not just pharmacy benefits. The structure and determination of such rebates may vary by industry, but the concept of a manufacturer conceding a greater discount based on an increase in market share or volume holds true. In pharmacy benefits, two principles matter most.
Not every drug receives a rebate. Manufacturers pay rebates when a PBM sets drug coverage in a way that drives market share to a particular product. This occurs in competitive categories that have multiple similar drugs. Manufacturers have no incentive to offer a rebate in a category that is not competitive.
Rebate values vary by drug, and even by claim. Highly competitive categories, more aggressive management strategies (e.g., formulary exclusions), and medications soon to lose patent protection tend to carry higher rebates as manufacturers work to maintain or increase market share.
If not every drug has a rebate and rebate values vary by drug and claim then how can a contract include a flat guarantee per claim? The answer is that a lot of assumptions need to be made to reach a flat guarantee per claim, and those assumptions are ultimately manipulatable by the PBM.
During the evaluation process you may calculate the expected rebate value by multiplying the guaranteed perbrand rebate by the number of branded claims and get an output. However, the actual yield six months later might be lower than expected. This is a result of overlooked contract definitions that will lower the denominator (number of claims) without impacting the numerator (rebate dollars) resulting in overstated per-claim rebate value. Rebate guarantees can also reward the wrong drug mix, because a PBM can improve its rebate performance by increasing utilization of guarantee-rich products that raise plan cost. Just like for pharmacy network discount guarantees, the ambiguity of manufacturer rebate payment guarantees makes accountability very difficult.
PBM Guarantees in Context
To help understand the two guarantee types discussed above, and to illustrate how strange they are relative to other industries, imagine this car-buying experience:
You visit a car dealership to shop for cars, but instead of being told how much the various cars cost you are told not to worry about the total price, since the seller has negotiated great discounts on various categories of car parts. You as the buyer have no control over which parts are going to be used, how they are classified, and whether the benchmark prices of the parts are inflated to create the sense of a greater discount.
The likely outcome of this shopping experience is that you would overpay for the car, even while receiving great discounts on all of the parts that went into it. This reflects the current state of the pharmacy benefits industry: increasing discounts and yet somehow, at the same time, everincreasing drug costs.
How to Evaluate PBM Contract Performance Guarantees
When evaluating pharmacy benefits costs, there are better ways than these manipulable guarantees for employers and brokers to drive PBM accountability. Some of these strategies include:
Work only with pass-through PBMs that do not take margin on drug costs and rebates. These margins incentivize PBMs to push pricier drugs to your health plan if doing so means higher margins for them.
Work with a transparent PBM that is willing and able to share claims-level cost details with you. If your PBM is unwilling to share data, it is likely because it is manipulating pricing in a way that would render its guarantees of dubious value.
Be careful when working with PBMs that offer both traditional and pass-through pricing across their books of business. Those PBMs will be incentivized to pass their higher-cost claims through to pass-through clients and lower-cost claims to traditional clients, where they keep the margin.
Evaluate your PBM’s performance based on per member per month (PMPM) or plan cost. This reflects the real cost of your pharmacy benefits. An effective PBM partner should be able to drive your drug costs down or at least keep them flat.
Those principles shape how a plan should read the guarantee language it already has, or the language it is about to sign.
Contract Terms to Confirm Before You Sign or Renew
Before relying on any guarantee, confirm how the contract answers four questions:
Measurement Level: A client-level guarantee is reconciled against your plan's own claims. An aggregate, or book-of-business, guarantee pools many plans, so your plan can fall short while the pool meets its target.
Exclusions and Definitions: Ask which drugs and claim types are excluded and how the contract defines brand, generic, specialty, and days supply. Milliman's guidance on PBM audits advises plan sponsors to check whether drugs excluded from contractual protections have been accurately defined and reflected.
Rebate Definition: Ask whether 100% of manufacturer rebates, manufacturer administrative fees, and price protection payments pass through to the plan, or only the amounts the contract labels as rebates.
Audit Rights: Confirm the right to audit both claims and rebates, with access to claims, rebate, and administrative data and a defined process for recovering amounts owed.
Federal rules are adding visibility as well. In October 2026, the U.S. Department of Labor released a final rule on PBM fee disclosure under ERISA. It requires PBMs serving large self-insured group health plans, generally those with 100 or more participants, to disclose direct and indirect compensation, including which manufacturer payments pass through to the plan and which the PBM retains.
The rule applies to plan years beginning on or after July 1, 2027, and gives covered plans the right to audit those disclosures at least once a year. Disclosure shows employers how a PBM is paid. The contract definitions still determine what each guarantee measures.
How SmithRx Approaches PBM Performance Guarantees
Employers evaluating a PBM need a measure of performance that contract definitions cannot reshape. We built SmithRx around the approaches above and measure our success by the pharmacy cost reductions plans realize, rather than by guarantee values.
We combine transparent economics with a fixed PMPM administrative fee and 100% pass-through of manufacturer rebates, so the plan pays what the pharmacy is paid, with no spread pricing, and our compensation does not increase when medication costs rise. That structure lets plan sponsors hold us to PMPM and plan cost over time. In 2025, SmithRx clients saw PMPM 20%+.
Discount and rebate guarantees still have a place in a PBM contract as a floor, provided the definitions behind them are clear. Pairing client-level terms, visible exclusions, audit rights, and claims-level data with PMPM trend gives benefits leaders a measure of PBM performance that tracks what the plan actually pays.
Frequently Asked Questions
What is a PBM rebate guarantee?
A PBM rebate guarantee is a contractual minimum rebate amount the PBM commits to pay the plan sponsor, usually set per brand claim and segmented by channel or days supply. Its real value depends on how the contract defines a rebate and which claims count toward the guarantee.
How can I tell if my PBM is honoring its guarantees?
Compare the PBM's guarantee reconciliation reports with your claims-level data, and use your contract's audit rights to verify pricing and rebate calculations independently. If PMPM rises while the PBM reports meeting its guarantees, review how claims were categorized and which were excluded.
When should employers review PBM performance guarantees?
Review guarantee terms well before an RFP or renewal, and reconcile them against claims-level data throughout the contract year. For large self-insured plans, the Department of Labor's final rule also requires PBMs to provide compensation disclosures reasonably ahead of a renewal, which gives plan sponsors another checkpoint.
SmithRx
SmithRx is the #1 Modern PBM, relentlessly focused on eliminating the conflicts and complexity of legacy pharmacy benefits. Built on radical transparency and fiduciary alignment, we empower employers to take control of their pharmacy spend and experience with our 100% pass-through model.


